TGFB1 and neoplasm: Additionally, aberrant expression of TGF‐β receptors, such as the overexpression of TGF‐βR I and II, disrupts normal signaling, reducing the tumor‐suppressive effects of TGF‐β and amplifying its protumorigenic impact [39, 40].